- Home
- KFFB vs NRSN Comparison
KFFB vs NRSN Comparison
Compare KFFB & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- NRSN
- Stock Information
- Founded
- KFFB 2005
- NRSN 2017
- Country
- KFFB United States
- NRSN Israel
- Employees
- KFFB N/A
- NRSN N/A
- Industry
- KFFB Savings Institutions
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- NRSN Health Care
- Exchange
- KFFB Nasdaq
- NRSN Nasdaq
- Market Cap
- KFFB 25.9M
- NRSN 26.0M
- IPO Year
- KFFB 2005
- NRSN 2021
- Fundamental
- Price
- KFFB $3.76
- NRSN $1.16
- Analyst Decision
- KFFB
- NRSN Buy
- Analyst Count
- KFFB 0
- NRSN 2
- Target Price
- KFFB N/A
- NRSN $14.00
- AVG Volume (30 Days)
- KFFB 1.5K
- NRSN 1.4M
- Earning Date
- KFFB 11-11-2025
- NRSN 09-17-2025
- Dividend Yield
- KFFB N/A
- NRSN N/A
- EPS Growth
- KFFB N/A
- NRSN N/A
- EPS
- KFFB N/A
- NRSN N/A
- Revenue
- KFFB $8,308,000.00
- NRSN N/A
- Revenue This Year
- KFFB N/A
- NRSN N/A
- Revenue Next Year
- KFFB N/A
- NRSN N/A
- P/E Ratio
- KFFB N/A
- NRSN N/A
- Revenue Growth
- KFFB 13.79
- NRSN N/A
- 52 Week Low
- KFFB $1.96
- NRSN $0.80
- 52 Week High
- KFFB $3.97
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- KFFB 75.63
- NRSN 45.23
- Support Level
- KFFB $3.12
- NRSN $1.14
- Resistance Level
- KFFB $3.44
- NRSN $1.28
- Average True Range (ATR)
- KFFB 0.07
- NRSN 0.15
- MACD
- KFFB 0.04
- NRSN 0.03
- Stochastic Oscillator
- KFFB 77.32
- NRSN 20.39
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.